Arbutus Biopharma
Data Breaches, Cyber Attacks and Security Report  ᛫ 
Last updated January 18, 2020

About Arbutus Biopharma

Company Overview

Arbutus Biopharma Corporation is a publicly traded (NASDAQ: ABUS) biopharmaceutical company with an expertise in liposomal drug delivery and RNA interference, and is developing drugs for hepatitis B infection. It is headquartered in Vancouver, British Columbia and has research facilities in Warminster, Pennsylvania.







Burnaby, BC, Canada.

Data Breaches and Security News

Arbutus Biopharma Security Rating

Sorry, this security report couldn't be loaded at this time. Please try again later.

UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Arbutus Biopharma is implementing good security practices.

Passed Checks

Passed{{ passedCheck.passTitle }}

Failed Checks

Warning{{ failedCheck.failTitle }}

View a free security report for Arbutus Biopharma

Get full security report ›

Related posts

Read more about the latest issues in cybersecurity

More security reports

Compare Arbutus Biopharma's security performance with other companies